James M. Christenson, Frcpc
Abstract
In the ASSENT-3 study, 6095 patients with ST-segment-elevation myocardial infarction received either enoxaparin (plus full-dose tenecteplase),
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
In the ASSENT-3 study, 6095 patients with ST-segment-elevation myocardial infarction received either enoxaparin (plus full-dose tenecteplase),
Key concepts: Tenecteplase, Medicine, Reteplase, Cardiology, Internal medicine, Myocardial infarction, Thrombolysis